EXAS
EXACT SCIENCES CORP
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$104.91
+0.00%Latest reported
- Last report date
- Feb 13, 2026
- EPS actual
- -$0.21
- EPS estimate
- -$0.11
- Revenue actual
- $878.4M
- Revenue estimate
- $860.9M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 9
- EPS misses (12Q)
- 3
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +25.9%
- Revenue beats (12Q)
- 12
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Feb 13, 2026 | -$0.11 | -$0.21 | Miss -94.57% | $878.4M |
| May 1, 2025 | -$0.37 | -$0.21 | Beat 43.24% | $706.8M |
| Feb 19, 2025 | -$0.29 | -$0.06 | Beat 79.31% | $713.4M |
| Jul 31, 2024 | -$0.37 | -$0.09 | Beat 75.68% | $699.3M |
| May 8, 2024 | -$0.47 | -$0.50 | Miss -5.27% | $637.5M |
| Feb 21, 2024 | -$0.53 | -$0.27 | Beat 49.06% | $646.9M |
| Nov 1, 2023 | -$0.48 | $0.00 | Beat 100.90% | $628.3M |
| Aug 1, 2023 | -$0.50 | -$0.45 | Beat 10.00% | $622.1M |
| Feb 21, 2023 | -$0.90 | -$0.72 | Beat 20.00% | $553.0M |
| Nov 3, 2022 | -$1.10 | -$0.84 | Beat 23.64% | $523.1M |
| Aug 2, 2022 | -$1.07 | -$0.94 | Beat 12.15% | $521.6M |
| Feb 22, 2022 | -$0.91 | -$1.28 | Miss -40.66% | $473.8M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of May 7, 2026